Lorenzo Refolo, Ph.D.

Dr. Lorenzo M. Refolo received a BSc. from the University of Connecticut, and was awarded a Ph.D. in Molecular Genetics from the Department of Microbiology and Molecular Genetics at the New Jersey State University of Medicine and Dentistry. Subsequently, Dr. Refolo trained as a post-doctoral fellow at Mt Sinai Medical Center in New York, investigating the molecular and cell biology of the Alzheimer's Amyloid Precursor Protein. After concluding his post-doctoral training Dr. Refolo served as Transgenics Group Leader at Athena Neurosciences and later held faculty positions at the Mayo Clinic Jacksonville and the Nathan Kline Institute for Psychiatric Research were he focused on animal studies aimed at understanding the role of cholesterol in the pathogenesis of Alzheimer's disease. In 2001, Dr. Refolo became the Scientific Director at the Institute for the Study of Aging, a private, disease-focused foundation with a mission to fund the discovery and clinical development of drugs for the treatment of Alzheimer's disease. Currently, Dr. Refolo is Program Director in the Neurodegeneration Cluster at NINDS where his major responsibility is the management of a portfolio of grants on ALS and Alzheimer's and Parkinson's diseases.